F. C. Breedveld

Active 1987–2023

Also published as
F C Breedveld
96
Papers
20,070
Citations
82
h-index
96
i10-index

Citations

Citations per year for F. C. Breedveld1975: 1 citations1985: 1 citations1987: 2 citations1989: 7 citations1990: 18 citations1991: 15 citations1992: 8 citations1993: 11 citations1994: 14 citations1995: 32 citations1996: 55 citations1997: 74 citations1998: 57 citations1999: 94 citations2000: 109 citations2001: 115 citations2002: 127 citations2003: 141 citations2004: 203 citations2005: 209 citations2006: 186 citations2007: 239 citations2008: 255 citations2009: 287 citations2010: 280 citations2011: 268 citations2012: 171 citations2013: 152 citations2014: 178 citations2015: 120 citations2016: 85 citations2017: 108 citations2018: 80 citations2019: 282 citations2020: 287 citations2021: 265 citations2022: 197 citations2023: 112 citations2024: 164 citations2025: 60 citations2026: 1 citations1976–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,366 citing papers, 18.2% of this breakdownUnited Kingdom: 822 citing papers, 11% of this breakdownNetherlands: 701 citing papers, 9.4% of this breakdownGermany: 451 citing papers, 6% of this breakdownFrance: 343 citing papers, 4.6% of this breakdownItaly: 328 citing papers, 4.4% of this breakdownCanada: 281 citing papers, 3.7% of this breakdownJapan: 221 citing papers, 2.9% of this breakdownSweden: 213 citing papers, 2.8% of this breakdownSpain: 210 citing papers, 2.8% of this breakdownAustralia: 207 citing papers, 2.8% of this breakdownAustria: 204 citing papers, 2.7% of this breakdown
0%18.2%Other 28.7%

Fields

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Immunology and Microbiology8.4%
  • Neuroscience1.2%
  • Nursing0.7%
  • Health Professions0.7%
  • Other1.7%

Topics

  • Rheumatoid Arthritis Research and Therapies16.3%
  • Systemic Lupus Erythematosus Research6.4%
  • Spondyloarthritis Studies and Treatments5.2%
  • Autoimmune and Inflammatory Disorders Research4.5%
  • Monoclonal and Polyclonal Antibodies Research2.7%
  • Osteoarthritis Treatment and Mechanisms2.2%
  • Other62.7%

Coauthors

All papers

Open in search
  1. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 812

  2. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

    Authors: , , , , , , , , , , - The Lancet 1994 cited by 1,704

  3. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2002 cited by 231

  4. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 111

  5. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 1,459

  6. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2005 cited by 321

  7. Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 20

  8. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2003 cited by 143

  9. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 462

  10. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

    Authors: , , , , , - Annals of the Rheumatic Diseases 2002 cited by 444

  11. Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial

    Authors: , , , , , - Annals of the Rheumatic Diseases 2000 cited by 224

  12. Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

    Authors: , , , , , , , , - Arthritis & Rheumatism 2006 cited by 212

  13. Using internet technology to deliver a home‐based physical activity intervention for patients with rheumatoid arthritis: A randomized controlled trial

    Authors: , , , , , , - Arthritis Care & Research 2006 cited by 164

  14. Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 158

  15. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.

    Authors: , , , , , - Annals of the Rheumatic Diseases 1992 cited by 151

  16. THE RELATION BETWEEN CLASS-SPECIFIC SERUM RHEUMATOID FACTORS AND AGE IN THE GENERAL POPULATION

    Authors: , , , - Lara D. Veeken 1993 cited by 85

  17. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2006 cited by 799

  18. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

    Authors: , , , , , , , - Arthritis & Rheumatism 2004 cited by 642

  19. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , H. G. Prentice, C Black, Alan Tyndall - Annals of the Rheumatic Diseases 2001 cited by 285

  20. Epidemiology of inclusion body myositis in the Netherlands: A nationwide study

    Authors: , , , , , , , , , , , , , , , - Neurology 2000 cited by 213

  21. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)

    Authors: , , , , , - Clinical & Experimental Immunology 1999 cited by 162

  22. Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip

    Authors: , , , , , - Annals of the Rheumatic Diseases 2003 cited by 156

  23. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis

    Authors: , , , , , - Annals of the Rheumatic Diseases 2004 cited by 153

  24. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis

    Authors: , , , , , - Lara D. Veeken 1998 cited by 144